These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30347956)

  • 41. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of Gout and Hyperuricemia in CKD.
    Vargas-Santos AB; Neogi T
    Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
    Glasnović M
    Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Importance of the hyperuricaemia, gout and gender nosological features in the activity of general practitioner - family doctor].
    Rudichenko VM
    Lik Sprava; 2012; (5):44-57. PubMed ID: 23534271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperuricemia].
    Gröbner W; Zöllner N
    Internist (Berl); 1995 Dec; 36(12):1207-21. PubMed ID: 8567232
    [No Abstract]   [Full Text] [Related]  

  • 47. [Epidemiology and clinical aspects of hyperuricemia and gout].
    Thiele P; Schröder HE
    Z Arztl Fortbild (Jena); 1980 Jul; 74(13-14):655-8. PubMed ID: 7434805
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hyperuricemia/gout].
    Peuke C
    Med Monatsschr Pharm; 2010 Nov; 33(11):429-32. PubMed ID: 21166253
    [No Abstract]   [Full Text] [Related]  

  • 49. [Genetic testing and gene-based testing for hyperuricemia and gout].
    Taniguchi A; Kamatani N
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():285-9. PubMed ID: 16416809
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperuricemia, gout and the kidney.
    Gibson T
    Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.
    Sharon Y; Schlesinger N
    Curr Rheumatol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Historical review of gout and hyperuricemia investigations].
    Nakamura T
    Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hyperuricemia in sickle cell disease in France].
    Arlet JB; Ribeil JA; Chatellier G; Pouchot J; de Montalembert M; Prié D; Courbebaisse M
    Rev Med Interne; 2012 Jan; 33(1):13-7. PubMed ID: 21907467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.
    Kamatani N; Hosoya T
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264
    [No Abstract]   [Full Text] [Related]  

  • 56. Intraosseous talar pseudotumour: an unusual presentation of gout.
    Cheung A; Allardice G
    Foot (Edinb); 2013; 23(2-3):86-7. PubMed ID: 23415761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular manifestation in gout: an unusual presentation of gout.
    Barranco-Trabi J; Mank V; Minns R; Ryan C; Roberts J
    Clin Rheumatol; 2022 May; 41(5):1613-1614. PubMed ID: 35092491
    [No Abstract]   [Full Text] [Related]  

  • 59. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.
    Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L
    Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Idiopathic hyperuricemia with overproduction of uric acid].
    Mizuta E; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.